ERBB2 and breast carcinoma: Lastly, we measured DLEU1 expression in a panel of breast cancer cell lines of different molecular subtypes [21], including luminal MCF7 and T47D, HER2-positive SK-BR-3, and TNBC MDA-MB-231, MDA-MB-436, and MDA-MB-468 cells.